MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Strona główna・Stock List・Karyopharm Therapeutics Inc

Karyopharm Therapeutics Inc

Closed

SectorHealthcare

5.91 -0.17

Buy Sell

Overview

Share price change

24h

Current

Min

5.85

Max

5.96

Key metrics
By Trading Economics
Income	-14M -37M
Sales	7.9M 38M
EPS	-4.07
Profit margin	-98.215
Employees	279
EBITDA	8.9M -24M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+115.85% upside

Market Stats
By TradingEconomics
Market Cap	14M 49M
Previous open	6.08
Previous close	5.91

News Sentiment

By Acuity

50%

148 / 371 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

5.9501 / 7.66 Support & Resistance

Karyopharm Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

17 paź 2025, 18:13 UTC

Major Market Movers

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

17 paź 2025, 17:05 UTC

Major Market Movers

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

18 paź 2025, 13:30 UTC

Acquisitions, Mergers, Takeovers

Deal Expected to Value Unit at Roughly $4B, Sources Say -- WSJ

18 paź 2025, 13:30 UTC

Acquisitions, Mergers, Takeovers

Deal Could Be Announced as Soon as Next Week, Sources Say -- WSJ

18 paź 2025, 13:30 UTC

Acquisitions, Mergers, Takeovers

Gucci Owner Kering Nears $4 Billion Sale of Beauty Unit to L'Oréal -- WSJ

18 paź 2025, 13:30 UTC

Acquisitions, Mergers, Takeovers

Gucci Parent Kering in Talks to Sell Beauty Business to L'Oréal, Sources Say -- WSJ

18 paź 2025, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

18 paź 2025, 07:00 UTC

Earnings

A Growing Nimby Movement Could Upend the Data Center Boom -- Barrons.com

17 paź 2025, 23:25 UTC

Acquisitions, Mergers, Takeovers

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17 paź 2025, 22:15 UTC

Market Talk

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17 paź 2025, 21:15 UTC

Market Talk

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

17 paź 2025, 21:07 UTC

Market Talk

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

17 paź 2025, 21:07 UTC

Market Talk

Global Equities Roundup: Market Talk

17 paź 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 paź 2025, 20:34 UTC

Market Talk

Deere Is Reaching the End of Its Downcycle -- Market Talk

17 paź 2025, 20:27 UTC

Market Talk

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

17 paź 2025, 19:46 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

17 paź 2025, 19:45 UTC

Market Talk

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

17 paź 2025, 18:45 UTC

Market Talk

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

17 paź 2025, 17:51 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 paź 2025, 17:51 UTC

Market Talk

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

17 paź 2025, 17:44 UTC

Market Talk

EQT Seen With Long-Term Growth Opportunities -- Market Talk

17 paź 2025, 17:35 UTC

Market Talk

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

17 paź 2025, 16:20 UTC

Market Talk

Earnings

Tech, Media & Telecom Roundup: Market Talk

17 paź 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 paź 2025, 16:14 UTC

Market Talk

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

17 paź 2025, 16:04 UTC

Market Talk

Home Improvement Demand Is Starting to Pick Up -- Market Talk

17 paź 2025, 15:58 UTC

Market Talk

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

17 paź 2025, 15:56 UTC

Earnings

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

17 paź 2025, 15:43 UTC

Market Talk

Global Equities Roundup: Market Talk

Peer Comparison

Price change

Karyopharm Therapeutics Inc Forecast

Price Target

By TipRanks

115.85% upside

12 Months Forecast

Average 12.8 USD 115.85%

High 21 USD

Low 6 USD

Based on 6 Wall Street analysts offering 12 month price targets forKaryopharm Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

Buy

Hold

Sell

Based on 6 analysts giving stock ratings to Karyopharm Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

5.9501 / 7.66Support & Resistance

Recent bullish events outweigh bearish events.

All events are bearish.

There are no events.

Sentiment

By Acuity

148 / 371 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

Other stocks from the sector

MDT

Medtronic PLC

95.62

↑ +0.66%

VEEV

Veeva Systems Inc

283

↓-3.27%

Agilent Technologies Inc

141.9

↑ +0.66%

HQY

HealthEquity Inc

91.19

↑ +0.35%

TLRY

Tilray Inc

1.55

↑ +1.31%

Karyopharm Therapeutics Inc

Overview

Share price change

Key metrics

Recommendations

Market Stats

News Sentiment

Technical Score

Karyopharm Therapeutics Inc Chart

Related News

Peer Comparison

Karyopharm Therapeutics Inc Forecast

Price Target

Rating Consensus

Technical Score

Sentiment

Financials

Other stocks from the sector